Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Convalescent plasma for early Ebola virus disease in Sierra Leone
ISRCTN13990511Phase 3Completed
- Sponsor
- University of Liverpool
- Start
- Mar 2015
- Countries
- 1
01
Overview
Phase 3, open-label trial of convalescent plasma (Heinrich-Heine University, Duesseldorf) in Ebola virus disease (EVD) (2 arms), sponsored by University of Liverpool. Primary endpoint: All-cause mortality at day 14 post intervention. Started Mar 2015; status: completed.
02
Drugs
convalescent plasma (Heinrich-Heine University, Duesseldorf)
03
Conditions
Ebola virus disease (EVD)
Beyond the preview
Go deeper on ISRCTN13990511.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13990511.